Article thumbnail

Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2

By Tú Nguyen-Dumont, Lars P Jordheim, Jocelyne Michelon, Nathalie Forey, Sandrine McKay-Chopin, Olga Sinilnikova, Florence Le Calvez-Kelm, Melissa C Southey, Sean V Tavtigian and Fabienne Lesueur
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). A survey of genetic and epigenetic variation affecting human gene expression.
  2. (2004). Allele-specific gene expression differences in humans. Hum Mol Genet 13(Spec No 2):R255–60 Lo
  3. (2010). Allelic expression imbalance at high-density lipoprotein cholesterol locus MMABMVK.
  4. (2008). Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk.
  5. (2007). Allelic imbalance in gene expression as a guide to cisacting regulatory single nucleotide polymorphisms in cancer cells.
  6. (2006). Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes.
  7. (2004). CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.
  8. (2010). Common germ-line polymorphism of C1QA and breast cancer survival.
  9. (2008). de la Chapelle A
  10. (2008). Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins? Hum Mutat 29:65–73.
  11. (2007). Extreme context specificity in differential allelic expression.
  12. (2005). kConFab Investigators
  13. (2002). Lowpenetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59. doi:10.1038/ ng879.
  14. (2005). Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species.
  15. (2005). Optimization of LightTyper genotyping assays.
  16. (2009). Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
  17. (2011). Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study.
  18. (2002). Small changes in expression affect predisposition to tumorigenesis.
  19. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance
  20. (2009). Tavtigian SV, Breast Cancer Family Registries (BCFR), Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
  21. (2006). The CHEK2 gene and inherited breast cancer susceptibility.
  22. (2003). The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/ BRCA2 multiple-case families.
  23. (2004). The history of cancer epigenetics.
  24. (2006). The RIN: an RNA integrity number for assigning integrity values to RNA measurements.